A Dual-Purpose Approach for an Anti-Emetic NK1R Antagonist as a Chemosensitizer and Cardioprotectant in a Preclinical Model of Triple-Negative Breast Cancer. [PDF]
Muñoz M +6 more
europepmc +1 more source
Your questions to the PBAC: Aprepitant - recommendations for PBS listing [PDF]
Jim Siderov
openalex +1 more source
Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer. [PDF]
Ghahremanloo A +5 more
europepmc +1 more source
Health-Related Quality of Life and Economic Analysis of Olanzapine Versus Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy in Malaysia [PDF]
Nurul Suhaida Badarudin +8 more
openalex +1 more source
Cost-consequence analysis of aprepitant compared to standard therapy (5-HT 3 + corticosteroids) for the prevention of highly emetogenic chemotherapy-induced nausea and vomit [PDF]
Roberto Ravasio, Giovanni Rosti
openalex +1 more source
Cannabinoid Hyperemesis Syndrome Treated With Fosaprepitant: A Case Report. [PDF]
Moore MD, Alzghari SK, Soliman AN.
europepmc +1 more source
Perioperative Anesthetic and Hormonal Considerations in a Patient With Anti-glutamic Acid Decarboxylase Encephalitis: A Case Report. [PDF]
McArdle IW, Malik H, Dotson S, Kohli A.
europepmc +1 more source
Trastuzumab-associated prurigo nodularis successfully treated with nemolizumab: A case report. [PDF]
Chen R +5 more
europepmc +1 more source

